Dermata Therapeutics, Inc. Logo

Dermata Therapeutics, Inc.

Medical dermatology company developing and commercializing OTC skin care products.

DRMA | US

Overview

Corporate Details

ISIN(s):
US2498451085
LEI:
Country:
United States of America
Address:
3525 DEL MAR HEIGHTS RD., #322, 92130 SAN DIEGO

Description

Dermata Therapeutics is a medical dermatology company that has shifted its strategic focus to developing and commercializing scientifically-backed over-the-counter (OTC) pharmaceutical products. The company leverages its proprietary Spongilla technology, which combines natural elements with FDA-listed OTC ingredients to create differentiated skin care solutions. Its initial product is a once-weekly acne kit, supported by clinical validation from its Phase 3 START-1 trial. Dermata plans to expand its portfolio with product candidates for other common skin conditions, such as psoriasis and seborrheic dermatitis, aiming to provide patients with accessible and effective treatments to manage their skin health.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Dermata Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Dermata Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Dermata Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Idorsia Ltd Logo
Biopharmaceutical company developing small-molecule medicines for multiple therapeutic areas.
Switzerland
IDIA
ILDONG HOLDINGS CO.,LTD  Logo
A holding company managing a diversified healthcare group in pharmaceuticals and bioscience.
South Korea
000230
IL DONG PHARMACEUTICAL CO., LTD. Logo
Develops, manufactures, and commercializes a broad range of healthcare products.
South Korea
249420
ILSUNG IS CO., LTD. Logo
Develops and manufactures antibiotics, cardiovascular agents, and anesthetics.
South Korea
003120
ILYANG PHARMACEUTICAL CO.,LTD Logo
Develops and manufactures a diverse range of pharmaceuticals and consumer health products.
South Korea
007570
I-Mab Logo
Global biotech company developing bispecific antibodies for immuno-oncology.
United States of America
IMAB
ImageneBio, Inc. Logo
Develops therapeutics for immunological, autoimmune, and inflammatory diseases.
United States of America
IMA
IMGT Corporation Limited Logo
Develops a drug delivery platform using focused ultrasound and nanotechnology.
South Korea
456570
Immatics N.V. Logo
Clinical-stage biopharma developing T cell receptor immunotherapies for cancer.
United States of America
IMTX
Immix Biopharma, Inc. Logo
Clinical-stage biopharma developing cell therapies and addressing CAR-T neurotoxicity.
United States of America
IMMX

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.